Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.20.2
Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Revenue:    
Total revenue $ 253,873 $ 510,240
Costs and expenses:    
Cost of products and services 175,146 309,712
Research and development 265,690 264,704
Selling and marketing 189,116 188,215
General and administrative 1,019,010 1,144,421
Total operating costs and expenses 1,648,962 1,907,052
Operating loss (1,395,089) (1,396,812)
Other (expense) income:    
Interest expense, net (1,571,800) (512,706)
Unrealized gain on investment in equity securities 149,371
(Loss) on extinguishment of liabilities (1,136,367) (40,810)
Other expense (104,845)
Total other expense (2,558,796) (658,361)
Net loss (3,953,885) (2,055,173)
Deemed dividends on beneficial conversion feature (1,060,199)
Preferred stock dividends (324,586) (355,610)
Net loss attributable to common shareholders $ (4,278,471) $ (3,470,982)
Net loss per share attributable to common stockholders - basic and diluted $ (1.62) $ (2.01)
Weighted average common stock shares outstanding used in the basic and diluted net loss per share calculation 2,648,039 1,723,557
Products, Services, Other [Member]    
Revenue:    
Total revenue $ 253,873 $ 510,240